Compare TROO & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TROO | RCEL |
|---|---|---|
| Founded | 2005 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.1M | 306.5M |
| IPO Year | 2008 | 2018 |
| Metric | TROO | RCEL |
|---|---|---|
| Price | $2.29 | $10.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.88 |
| AVG Volume (30 Days) | ★ 358.0K | 337.0K |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.20 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $71,610,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $49.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.45 |
| 52 Week Low | $1.02 | $3.22 |
| 52 Week High | $5.28 | $11.39 |
| Indicator | TROO | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 57.48 | 61.64 |
| Support Level | $2.13 | $3.64 |
| Resistance Level | $2.32 | $10.77 |
| Average True Range (ATR) | 0.20 | 0.54 |
| MACD | 0.02 | -0.23 |
| Stochastic Oscillator | 82.26 | 34.08 |
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.